Comparison Overview

Teva Pharmaceuticals

VS

Alembic Pharmaceuticals Limited

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, undefined, 6944020, IL
Last Update: 2025-12-17
View Profile
Between 800 and 849
http://www.tevapharm.com

At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to push the boundaries of science, discover life-changing treatments, and deliver quality medicines. If patients have a need, we’re already working to address it. Because here, we are all in for better health. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: [email protected] Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 29,653
Subsidiaries: 5
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Alembic Pharmaceuticals Limited

Alembic Road, Vadodara, 390003, IN
Last Update: 2025-12-17
Between 750 and 799
http://www.alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 13,958
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/alembic.jpeg
Alembic Pharmaceuticals Limited
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Teva Pharmaceuticals
100%
Compliance Rate
0/4 Standards Verified
Alembic Pharmaceuticals Limited
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Teva Pharmaceuticals in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2025.

Incident History — Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Incident History — Alembic Pharmaceuticals Limited (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
Incidents

No Incident

https://images.rankiteo.com/companyimages/alembic.jpeg
Alembic Pharmaceuticals Limited
Incidents

No Incident

FAQ

Teva Pharmaceuticals company demonstrates a stronger AI Cybersecurity Score compared to Alembic Pharmaceuticals Limited company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Alembic Pharmaceuticals Limited company has disclosed a higher number of cyber incidents compared to Teva Pharmaceuticals company.

In the current year, Alembic Pharmaceuticals Limited company and Teva Pharmaceuticals company have not reported any cyber incidents.

Neither Alembic Pharmaceuticals Limited company nor Teva Pharmaceuticals company has reported experiencing a ransomware attack publicly.

Neither Alembic Pharmaceuticals Limited company nor Teva Pharmaceuticals company has reported experiencing a data breach publicly.

Neither Alembic Pharmaceuticals Limited company nor Teva Pharmaceuticals company has reported experiencing targeted cyberattacks publicly.

Neither Teva Pharmaceuticals company nor Alembic Pharmaceuticals Limited company has reported experiencing or disclosing vulnerabilities publicly.

Neither Teva Pharmaceuticals nor Alembic Pharmaceuticals Limited holds any compliance certifications.

Neither company holds any compliance certifications.

Teva Pharmaceuticals company has more subsidiaries worldwide compared to Alembic Pharmaceuticals Limited company.

Teva Pharmaceuticals company employs more people globally than Alembic Pharmaceuticals Limited company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Teva Pharmaceuticals nor Alembic Pharmaceuticals Limited holds SOC 2 Type 1 certification.

Neither Teva Pharmaceuticals nor Alembic Pharmaceuticals Limited holds SOC 2 Type 2 certification.

Neither Teva Pharmaceuticals nor Alembic Pharmaceuticals Limited holds ISO 27001 certification.

Neither Teva Pharmaceuticals nor Alembic Pharmaceuticals Limited holds PCI DSS certification.

Neither Teva Pharmaceuticals nor Alembic Pharmaceuticals Limited holds HIPAA certification.

Neither Teva Pharmaceuticals nor Alembic Pharmaceuticals Limited holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hitachi Vantara Pentaho Data Integration and Analytics Community Dashboard Framework prior to versions 10.2.0.4, including 9.3.0.x and 8.3.x display the full server stack trace when encountering an error within the GetCdfResource servlet.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
References
Description

Pentaho Data Integration and Analytics Community Dashboard Editor plugin versions before 10.2.0.4, including 9.3.0.x and 8.3.x, deserialize untrusted JSON data without constraining the parser to approved classes and methods.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References
Description

A security flaw has been discovered in CTCMS Content Management System up to 2.1.2. The impacted element is an unknown function in the library /ctcms/libs/Ct_Config.php of the component Backend System Configuration Module. The manipulation of the argument Cj_Add/Cj_Edit results in code injection. The attack can be executed remotely. The exploit has been released to the public and may be exploited.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A vulnerability was identified in CTCMS Content Management System up to 2.1.2. The affected element is the function Save of the file /ctcms/libs/Ct_App.php of the component Backend App Configuration Module. The manipulation of the argument CT_App_Paytype leads to code injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Weblate is a web based localization tool. In versions prior to 5.15, it was possible to accept an invitation opened by a different user. Version 5.15. contains a patch. As a workaround, avoid leaving one's Weblate sessions with an invitation opened unattended.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss4
Base: 1.0
Severity: HIGH
CVSS:4.0/AV:L/AC:H/AT:P/PR:L/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References